BRIEF-Kalytera Therapeutics says Robert Farrell will assume role of interim CEO

* Kalytera Therapeutics Inc - Robert Farrell, J.D., president and cfo of Kalytera, will assume role of interim chief executive officer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.